相关实验视频

Updated: May 1, 2026

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Published on: September 9, 2011

泽布拉林通过诱导瘤免疫性和通过cGAS-STING通路改善抗原处理来增强抗瘤免疫力

Yong Zhang^1,2, Heng Zhao^1,2, Weili Deng^1,2

¹Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Fujian Normal University Qishan Campus, Fuzhou, Fujian Province, 350117, China.

Communications biology

|May 16, 2024

概括

像泽布拉林这样的DNA甲基转移酶抑制剂 (DNMTi) 通过促进树突细胞活动和T细胞反应来增强抗瘤免疫力. 这种表观遗传方法提高了癌症免疫性,并促进了瘤细胞的杀死.

科学领域:

免疫学免疫学免疫学
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
癌症生物学癌症生物学

背景情况:

基因甲基化是影响抗瘤免疫反应的关键表观遗传调节剂.
DNA甲基转移酶抑制剂 (DNMTi) 在某些癌症中显示出治疗前景,但它们在弥合先天性和适应性免疫力的机制尚未完全理解.

研究的目的:

阐明DNMTi,特别是泽布拉林如何调节免疫系统以抑制瘤生长.
调查泽布拉林在增强瘤免疫性和T细胞介导的抗瘤活性方面的作用.

主要方法:

在体内和体外实验中使用泽布拉林.
树突细胞成熟的分析,抗原呈现细胞 (APC) 活动,和细胞化.
对cGAS-STING-NF-κB/IFNβ信号通路的评估.
对抗原处理和呈现机器 (AgPPM) 和T细胞原始化的评估.

主要成果:

泽布拉林促进树突细胞成熟和APC活动,增强瘤细胞的细胞分裂.
泽布拉林激活了cGAS-STING-NF-κB/IFNβ通路,增加了瘤细胞的免疫性.
用泽布拉林对抗原处理和呈现机器 (AgPPM) 的调节.
观察到增强的CD4+和CD8+T细胞介导的瘤细胞杀死.

结论:

DNMTi泽布拉林通过增强先天免疫信号和APC功能来重建瘤免疫性.
泽布拉林促进有效的T细胞原始化和效应器功能,导致瘤细胞的消除.
使用DNMTi和免疫疗法的联合治疗有可能改善癌症治疗结果.

更多相关视频

Generation of Zebrafish Larval Xenografts and Tumor Behavior Analysis

Generation of Zebrafish Larval Xenografts and Tumor Behavior Analysis

Published on: June 19, 2021

Zebrafish Model of Neuroblastoma Metastasis

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.